By analyzing key enzymes in a new way, an international team led by researchers at Weill Cornell Medicine has discovered how a well-known signaling molecule can either stimulate or suppress tumor growth depending on where it’s produced.
A free weekly workshop sponsored by Cornell’s Center for Cultural Humility through Oct. 24 highlights the work of upstate New York authors and helps them enhance their writing.
An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers.
A cellular process known as autophagy that helps rid cells of debris may be impaired in pregnant women who go on to develop postpartum depression, according to new research from Weill Cornell Medicine.
The blood stem cell mutation, known as DNMT3A R882, leads to the growth of a large population of circulating blood cells that also contain this mutation.
Aggregates of a protein spread in the brains of people with Parkinson’s disease through a cellular waste-ejection process, suggests a new study led by Weill Cornell Medicine researchers.
Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer.
